Omalizumab ameliorates extrarespiratory symptoms in patients with aspirin-exacerbated respiratory disease.
Hayashi H, Fukutomi Y, Mitsui C, Kajiwara K, Watai K, Tomita Y, Kamide Y, Tsuburai T, Sekiya K, Ishii M, Hasegawa Y, Taniguchi M.
Hayashi H, et al. Among authors: tsuburai t.
J Allergy Clin Immunol. 2023 Jun;151(6):1667-1672.e2. doi: 10.1016/j.jaci.2023.03.014. Epub 2023 Mar 24.
J Allergy Clin Immunol. 2023.
PMID: 36967017
Free article.
Clinical Trial.